| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Gene Transcription


*
Department of Paediatrics, Teikyo University School of Medicine, Tokyo,
Japan
Department of Physiology, University of Birmingham, Birmingham, United
Kingdom
Department of Immunology, National Children's Medical Centre, Tokyo,
Japan.
Correspondence to Dr. Akio Nakamura, Department of Paediatrics, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173, Japan. Phone: 03-3964-1211 (ext. 1480); Fax: 03-3579-8212; E-mail: akio{at}med.teikyo-u.ac.jp
Abstract. Exposure of renal tubular epithelial cells to shiga
toxin 2 (Stx-2) causes cytotoxicity, and the potency of this toxin is enhanced
in the presence of tumor necrosis factor
(TNF-
). It has
been shown that Stx-2 induces TNF-
production and that activation of
ß2-adrenoceptors downregulates TNF-
. However, little is
known about the signaling pathway by which ß2-adrenoceptor
agonists suppress the Stx-2induced TNF-
gene transcription. The
possible signaling components involved in this pathway were investigated.
Human adenocarcinomaderived renal tubular epithelial cells (ACHN) were
exposed to Stx-2 in the presence or absence of a
ß2-adrenoceptor agonist. Mitogen-activated protein kinase
(MAPK), activating protein1 (AP-1), and nuclear factor
B
(NF-
B) were measured to evaluate the regulatory mechanisms involved in
TNF-
gene transcription. Stx-2 (4 pg/ml) stimulated MAPK (p42/p44, p38)
and AP-1 and increased TNF-
promoter activity by 2.4-fold. The increase
in TNF-
was attenuated by both a p42/p44 inhibitor, PD098059
(10-6 M), and a p38 inhibitor, SB203580 (10-6 M), and
AP-1binding activity was inhibited by PD098059. Terbutaline
(10-6 M to 10-8 M) suppressed MAPK (p42/p44, p38),
NF-
B (p50, p65), and TNF-
promoter activity in a dose-dependent
way that was prevented by the ß2-adrenoceptor antagonist,
ICI118,551. However, inhibition of MAPK (p42/p44) and TNF-
promoter
activity was partially prevented by the cAMP-protein kinase (PKA) inhibitors,
H-89 (5 x 10-6 M) and KT5720 (10-5 M), whereas the
suppression of p38 MAPK or NF-
B (p50) was not blocked by these
inhibitors. The suppression of NF-
B (p65) was completely overcome by
H-89 or KT5720. In summary, the downregulation of TNF-
transcription by
terbutaline was mediated by an inhibitory effect of
ß2-adrenoceptor activation on MAPK (p42/p44, p38) and
NF-
B (p50/p65), which were exerted through a cAMP-PKA pathway and a
cAMP-independent mechanism. It is likely that cAMP-PKA and MAPK (p42/p44, p38)
may play a critical role in the regulation of the Stx-2induced
TNF-
transcription via ß2-adrenoceptor activation.
This article has been cited by other articles:
![]() |
C. Zanchi, C. Zoja, M. Morigi, F. Valsecchi, X. Y. Liu, D. Rottoli, M. Locatelli, S. Buelli, A. Pezzotta, P. Mapelli, et al. Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin J. Immunol., July 15, 2008; 181(2): 1460 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morigi, S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi, and C. Zoja Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling Am. J. Pathol., December 1, 2006; 169(6): 1965 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakamura, A. Imaizumi, Y. Yanagawa, T. Kohsaka, and E. J. Johns {beta}2-Adrenoceptor Activation Attenuates Endotoxin-Induced Acute Renal Failure J. Am. Soc. Nephrol., February 1, 2004; 15(2): 316 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Smith, A. V. Kane, S. T. Campbell, D. W. K. Acheson, B. H. Cochran, and C. M. Thorpe Shiga Toxin 1 Triggers a Ribotoxic Stress Response Leading to p38 and JNK Activation and Induction of Apoptosis in Intestinal Epithelial Cells Infect. Immun., March 1, 2003; 71(3): 1497 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Tarr Basic Fibroblast Growth Factor and Shiga Toxin-O157:H7-Associated Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., March 1, 2002; 13(3): 817 - 820. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673